Monthly Archives - March 2020

CORRECTING and REPLACING Neuraly Announces First Patient Dosed in Phase 2 Clinical Trial of NLY01 for Patients with Parkinson’s Disease

All mentions of NLY01 have been corrected -- Neuraly, a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced the dosing of the first patient in its Phase 2 clinical trial of NLY01 for Parkinson’s disease. Read more >>
Read more...

PlaceMe opens the first official co-living building in MA

PlaceMe, Boston’s pioneer co-living company, is launching the first official co-living building in Cambridge, MA. Starting April 1, 2020, the three-story building will accommodate 26 residents, offering all the benefits of the shared living concept: no-hassle moving, fully furnished units, a prime location at accessible rents which include utilities, wifi, and cleaning of shared areas, as well as dedicated community events.Read more >>
Read more...